carnitine has been researched along with Myasthenia Gravis in 6 studies
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mechanism(s) of immune checkpoint inhibitor (ICI)-induced myasthenia gravis (MG), an immune-related adverse event (irAE) that is fatal and limits subsequent ICI use, remain unexplored." | 1.72 | Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis. ( Chen, L; Gao, W; Gong, Q; Guo, R; Jin, S; Li, J; Liu, X; Shao, YW; Shen, L; Sun, C; Wang, Q; Wang, W; Wang, Z; Wu, L; Xu, J; Yin, JC; Zhang, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W | 3 |
| Wu, L | 3 |
| Jin, S | 3 |
| Li, J | 3 |
| Liu, X | 3 |
| Xu, J | 3 |
| Zhang, W | 3 |
| Gong, Q | 3 |
| Sun, C | 3 |
| Wang, W | 3 |
| Wang, Z | 3 |
| Shao, YW | 3 |
| Yin, JC | 3 |
| Shen, L | 3 |
| Chen, L | 3 |
| Wang, Q | 3 |
| Guo, R | 3 |
| Bazzato, G | 2 |
| Coli, U | 1 |
| Landini, S | 1 |
| Mezzina, C | 2 |
| Ciman, M | 2 |
| Kaeser, HE | 1 |
| Clair, F | 1 |
| Caillat, S | 1 |
| Soufir, JC | 1 |
| Lafforgue, B | 1 |
| Drüeke, T | 1 |
| Saïd, G | 1 |
| Buxton, PH | 1 |
| Guarnieri, G | 1 |
2 reviews available for carnitine and Myasthenia Gravis
| Article | Year |
|---|---|
Drug-induced myasthenic syndromes.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Autoimmune Diseas | 1984 |
Pathology of muscle.
Topics: Adult; Carnitine; Carnitine O-Palmitoyltransferase; Child; Child, Preschool; Denervation; Female; Gl | 1980 |
4 other studies available for carnitine and Myasthenia Gravis
| Article | Year |
|---|---|
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Myasthenia-like syndrome after D,L- but not L-carnitine.
Topics: Carnitine; Humans; Isomerism; Myasthenia Gravis | 1981 |
[Myasthenic syndrome induced by D,L-carnitine in a chronic hemodialysis patient].
Topics: Carnitine; Humans; Male; Middle Aged; Myasthenia Gravis; Renal Dialysis | 1984 |
Myasthenia-like syndrome associated with carnitine in patients on long-term haemodialysis.
Topics: Carnitine; Humans; Myasthenia Gravis; Renal Dialysis | 1979 |